CVE-2026-42423OpenClaw before 2026.4.8 contains an approval-timeout fallback mechanism that bypasses strictInlineEval explicit-approval requirements on gateway and node exec hosts.
Updated under an hour ago ()
Does this affect you?
It affects openclaw. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
OpenClaw before 2026.4.8 contains an approval-timeout fallback mechanism that bypasses strictInlineEval explicit-approval requirements on gateway and node exec hosts. Attackers can exploit this timeout fallback to execute inline eval commands that should require explicit user approval, circumventing the intended security boundary.
- CVSS
- 7.5 HIGH (v3.1, NVD)CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-636
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Analyzed
- Record last updated
- Jun 17, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
openclaw openclaw openclaw:openclaw | before 2026.4.8 | NVD |
References
- https://github.com/openclaw/openclaw/commit/d7c3210cd6f5fdfdc1beff4c9541673e814354d5patch
- https://github.com/openclaw/openclaw/security/advisories/GHSA-q2gc-xjqw-qp89vendor-advisory
- https://www.vulncheck.com/advisories/openclaw-strictinlineeval-approval-boundary-bypass-via-approval-timeout-fallbackthird-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.